99% Synthetic Tetrapeptide Raw Peptide Powder Cardiogen Cardiovascular Bioregulator Peptide Vial Cardiogen for Research Peptide

• Customization: Available
• CAS No.: 2460055-10-9
• Formula: C50h69n15o9
• EINECS: 1308068-626-2
• Type: Research Peptides
• Appearance: Powder
• Quality: Refined
• Colour: White
• Content: Standard
• Usage: Laboratory Reagents
• Source: Dry Powder
• Habit Appellation: Fine Chemicals
• Application: Scientific Research
• Property: Protein and Peptide
• Specific Usage: Research Use Only
• Note: No Tfa Salt
• From: Authoried Regluar Workshop
• Raw Powder: 1g/Bottle
• Vials: 20mg
• Attention: Research Use Only
• Transport Package: Customized
• Specification: 1G/Bottle 2mg/5mg/10mg per vial
• Trademark: Hoconbio
• Origin: China
• Production Capacity: 50000kits Per Month

Product Description

Cardiogen, a synthetic tetrapeptide, has been theorized to significantly stimulate cell proliferation in young and aged mice models. This suggests that Cardiogen may stimulate the formation of heart muscle cells. Researchers further hypothesize that Cardiogen may reduce p53 protein production, which might slow the death of cells via programmed cell death. As suggested by the results of the research, Cardiogen may have the potential to reduce p53 expression. The p53 protein has been called the "guardian of the genome" owing to the ramifications of its discovery as a tumor suppressor and cell-cycle regulator for the field of oncology. It is believed that p53 may induce apoptosis or programmed cell death when functional. Therefore, if Cardiogen has been speculated to reduce p53 expression, it may be able to prevent cardiac tissue from apoptosing.

Cardiogen Peptide and Cancer

Cardiogen has been suggested to inhibit apoptosis in cardiomyocytes by lowering p53 expression, but it may have the opposite effect in tumor cells. The tumor-modifying potential of Cardiogen, which was explored on rat models with M-1 sarcoma, purported that apoptosis on tumor cells looked to be greater than typical and beyond control. As suggested by the research, this may have occurred because of increased apoptosis among tumor cells and the formation of necrotic hemorrhage. This proliferative activity might suggest that the reduction of tumor development by a cytostatic substance is not caused by the presentation's direct action on the tumor. Scientists speculated that "Morphological signs indicate a specific mechanism of Cardiogen action, realized through the tumor's vascular network." Therefore, tumor cells may be granted this apoptotic process due to inducing alterations in their vascular supply.

Product Name	Bronchogen
CAS NO.	N/A
Other name	Ala-Glu-Asp-Leu
Appearance	White freeze-dried powder
Purity	98% HPLC
Application	Research peptides
Shelf Life	24 Months
Storage	Store at a temperature of 2-8 degrees, protected from light.

Bronchogen is a dietary supplement with а synthesized bronchial peptide. It normalizes the function of the bronchi by reducing their peptide deficiency and restoring protein synthesis inside their cells.

 

Bronchogen is recommended for everyone whose bronchi may be compromised, especially smokers, elderly people, and those with bronchial spasm, acute and chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other respiratory diseases.

 

Bronchogen can be easily combined with other supplements and medicines and should be used in addition to conventional medical treatments.